![]() |
市场调查报告书
商品编码
1989129
情绪食品市场预测至2034年-全球产品类型、主要成分、功能、特性、包装、年龄层、目标受众、通路和区域分析Mood Food Market Forecasts to 2034 - Global Analysis By Product Type, Key Ingredient, Functional Benefit, Nature, Packaging Format, Age Group, Target Group, Distribution Channel, and By Geography |
||||||
根据 Stratistics MRC 的数据,预计到 2026 年,全球情绪食品市场规模将达到 25 亿美元,并在预测期内以 12.9% 的复合年增长率增长,到 2034 年将达到 67 亿美元。
情绪食品是指透过肠脑轴对心理健康、认知功能和情绪平衡有正面影响的功能性产品。这些食品和饮料含有适应原、促智剂、益生菌和植物萃取物,旨在减轻压力、提高注意力并促进放鬆。该市场涵盖机能饮料、点心棒、乳製品替代品和膳食补充剂,定位为寻求天然心理健康解决方案的消费者的日常消费品。
压力和焦虑症盛行率增加
全球心理健康挑战已达到流行病的程度,压力相关症状影响着各行各业数百万人。这种普遍性促使消费者寻求预防性的营养干预措施,以在不依赖药物的情况下维持情绪平衡。 「情绪食品」以其价格实惠、成分客观的解决方案吸引着那些寻求自然心理健康方法的人们,这些方案可以融入日常饮食习惯。随着人们对心理健康话题的日益关注和接受,功能性食品也进一步推动了相关产品的普及,消费者公开寻求并共用透过选择机能性食品来管理压力、提高专注力和稳定情绪的解决方案。
缺乏关于有效性的科学证据
许多声称能改善情绪的成分缺乏强有力的临床证据来支持其心理效应,这导致注重实证的消费者对其持怀疑态度。传统使用的适应原和植物成分往往缺乏现代研究支持,而新兴化合物则需要相当长的时间进行检验。这种科学上的空白限制了市场宣传,也使消费者教育变得更加复杂。医疗保健专业人员可能不愿意推荐缺乏可靠疗效数据的产品,限制了专家建议的管道。製造商必须投入大量资金进行研发以证明其有效性,这导致研发成本增加,并延缓了有前景的成分和配方上市的时间。
透过与数位健康整合实现个人化
消费者基因组学、微生物组检测和数位健康平台的进步,使得改善情绪的食品推荐实现了前所未有的个人化。消费者现在可以透过智慧型手机应用程式和线上评估,获得根据其独特的基因谱、肠道微生物组和压力反应量身定制的产品提案。这种个人化使个人能够体验到符合自身特定需求的成果,从而提高对产品功效的认知,并增强消费者的参与度。食品製造商与数位健康公司之间的合作,创造了新的分销管道和数据丰富的反馈循环,从而能够持续改进产品,并透过客製化的健康之旅增强消费者忠诚度。
对功能性声明的监管
全球监管机构正日益严格地审查食品饮料生产商关于心理益处的宣传。卫生部门要求提供充分的科学证据,才能批准将成分与情绪改善、压力缓解或认知功能增强联繫起来的宣传。这种法规环境带来了合规风险,做出未经证实宣传的公司可能面临整改措施、产品查封或强制更改标籤。由于不同司法管辖区的法规各不相同,企业需要根据当地情况调整产品配方和行销材料,这使得国际市场扩张变得更加复杂。小规模、具有创新精神的公司在法律和科学资源有限的情况下,面临着应对复杂监管环境的独特挑战。
在全球隔离、不确定性和健康焦虑加剧的背景下,新冠肺炎疫情大大提升了消费者对心理健康的关注。封锁措施促使人们寻求居家养生之道,包括有助于情绪平衡的机能性食品。供应链中断最初为原材料采购带来了挑战,但电子商务的快速发展确保了市场供应的持续畅通。疫情对心理健康的持续影响巩固了消费者对情绪调节产品的需求。即使在急性健康问题消退之后,消费者仍然高度重视饮食与心理健康之间的关联。
在预测期内,机能饮料细分市场预计将占据最大的市场份额。
在预测期内,机能饮料预计将占据最大的市场份额。这主要得益于其便利性、消费者对其形式的熟悉度以及频繁的消费需求。即饮饮料、功能性粉末和草本茶能够无缝融入日常生活,最大限度地减少消费者寻求心理健康益处时的行为改变。与固态食物相比,饮料中的成分吸收速度较快,因此其效果也更容易显现。在杂货店、便利商店和专卖店等成熟的分销管道为消费者提供了广泛的购买管道,而口味和配方方面的不断创新也持续扩大了其对所有寻求便捷情绪调节解决方案的消费者群体的吸引力。
预计在预测期内,CBD和大麻萃取物细分市场将实现最高的复合年增长率。
在预测期内,CBD和工业大麻萃取物细分市场预计将呈现最高的成长率,这主要得益于合法化进程的推进以及消费者对天然抗焦虑产品日益增长的需求。这些化合物与人体的内源性大麻素系统相互作用,可能有助于促进平静和情绪平衡,且不产生精神活性作用。随着研究显示它们对压力、睡眠和情绪调节的正面影响,社会对其的接受度也迅速提高。饮料、零食和膳食补充剂等产品的创新正在加速市场渗透,而名人代言和社交媒体的曝光则将这些成分介绍给全球范围内日益增长的、接受度更高的消费者群体。
在整个预测期内,北美预计将保持最大的市场份额,这得益于其成熟的健康文化、较高的可支配收入以及对机能性食品潮流的早期接受。该地区的消费者渴望尝试能够改善情绪的成分,并且愿意为提升心理健康的益处支付更高的价格。由于涵盖天然食品零售商和主流杂货店通路的广泛分销网络,消费者可以轻鬆购买到相关产品。在具有影响力的健康媒体和充满活力的Start-Ups系统不断推动创新的同时,美国和加拿大针对CBD和工业大麻萃取物的法规结构正在为成分实验创造一个系统化的市场环境。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于当地对有助于心理健康的传统药材成分的深厚文化亲和性。印度的阿育吠陀医学原理以及全部区域的传统中医实践,长期以来都将具有情绪稳定作用的草药和植物成分纳入日常饮食,从而赢得了消费者的广泛认可。快速的都市化、可支配收入的成长以及日益加剧的工作压力,正在扩大寻求便捷心理健康解决方案的潜在消费群体。国际机能性食品品牌透过策略合作进入这些市场,而当地製造商则开发针对本地情况的配方,这些合作正在加速全部区域相关产品的接受度。
According to Stratistics MRC, the Global Mood Food Market is accounted for $2.5 billion in 2026 and is expected to reach $6.7 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Mood foods are functional products formulated with ingredients that positively influence mental wellbeing, cognitive function, and emotional balance through the gut-brain axis. These foods and beverages incorporate adaptogens, nootropics, probiotics, and botanical extracts designed to reduce stress, enhance focus, and promote relaxation. The market spans functional beverages, snack bars, dairy alternatives, and dietary supplements positioned as everyday consumables for consumers seeking natural mental wellness solutions.
Rising prevalence of stress and anxiety disorders
Global mental health challenges have reached epidemic proportions, with stress-related conditions affecting millions across all demographics. This widespread prevalence drives consumers toward proactive nutritional interventions that support emotional balance without pharmaceutical intervention. Mood foods offer accessible, stigma-free solutions integrated into daily eating routines, appealing to individuals seeking natural approaches to mental wellness. The normalization of conversations around mental health further encourages product trial, as consumers openly seek and share solutions for stress management, focus enhancement, and mood stabilization through functional food choices.
Limited scientific validation of efficacy
Many mood-enhancing ingredients lack robust clinical evidence supporting their psychological benefits, creating skepticism among evidence-focused consumers. Adaptogens and botanicals with traditional use histories often have limited modern research, while emerging compounds face lengthy validation timelines. This scientific gap restricts marketing claims and complicates consumer education efforts. Healthcare professionals may hesitate to recommend products without strong efficacy data, limiting professional endorsement channels. Manufacturers must invest substantially in research to substantiate benefits, increasing development costs and delaying market entry for potentially promising ingredients and formulations.
Personalization through digital health integration
Advances in consumer genomics, microbiome testing, and digital health platforms enable unprecedented personalization of mood food recommendations. Consumers can now receive product suggestions tailored to their unique genetic profiles, gut compositions, and stress responses through smartphone applications and online assessments. This personalization enhances perceived efficacy and consumer engagement, as individuals experience results aligned with their specific needs. Partnerships between food manufacturers and digital health companies create new distribution channels and data-rich feedback loops, enabling continuous product refinement and strengthening consumer loyalty through customized wellness journeys.
Regulatory scrutiny of functional claims
Regulatory authorities worldwide increasingly scrutinize psychological benefit claims made by food and beverage manufacturers. Health agencies require substantial scientific evidence before permitting statements linking ingredients to mood improvement, stress reduction, or cognitive enhancement. This regulatory environment creates compliance risks, with companies facing enforcement actions, product seizures, or mandatory label changes for unsupported claims. Evolving regulations across jurisdictions complicate international market expansion, as formulations and marketing materials require region-specific adaptations. Small innovators face particular challenges navigating complex regulatory landscapes with limited legal and scientific resources.
The COVID-19 pandemic dramatically elevated consumer focus on mental wellness as isolation, uncertainty, and health anxieties intensified globally. Lockdowns prompted exploration of at-home wellness routines, including functional foods supporting emotional balance. Supply chain disruptions initially challenged ingredient sourcing, but accelerated e-commerce adoption enabled continued market access. The pandemic's enduring mental health legacy established sustained demand for mood-supporting products, with consumers maintaining heightened awareness of the connection between diet and psychological wellbeing long after acute health concerns receded.
The Functional Beverages segment is expected to be the largest during the forecast period
The Functional Beverages segment is expected to account for the largest market share during the forecast period, driven by convenience, rapid format familiarity, and frequent consumption occasions. Ready-to-drink beverages, functional powders, and herbal infusions integrate seamlessly into daily routines, requiring minimal behavioral change from consumers seeking mental wellness benefits. Beverages offer faster ingredient absorption compared to solid foods, enhancing perceived efficacy. Established distribution channels across grocery, convenience, and specialty retailers provide broad consumer access, while innovation in flavors and formulations continuously expands appeal across demographics seeking accessible mood support solutions.
The CBD & Hemp Extracts segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the CBD & Hemp Extracts segment is predicted to witness the highest growth rate, fueled by expanding legalization and mounting consumer interest in natural anxiety relief. These compounds interact with the body's endocannabinoid system, potentially promoting calm and emotional balance without psychoactive effects. Mainstream acceptance has grown rapidly as research suggests benefits for stress, sleep, and mood regulation. Product innovation across beverages, snacks, and supplements accelerates market penetration, while celebrity endorsements and social media exposure introduce these ingredients to increasingly receptive consumer demographics worldwide.
During the forecast period, the North America region is expected to hold the largest market share, supported by sophisticated wellness culture, high disposable incomes, and early adoption of functional food trends. The region's consumers demonstrate strong willingness to experiment with mood-enhancing ingredients and pay premiums for mental wellness benefits. Extensive distribution networks across natural food retailers and mainstream grocery channels provide broad consumer access. Influential wellness media and vibrant startup ecosystems continuously introduce innovation, while regulatory frameworks for CBD and hemp extracts in the United States and Canada create structured market environments for ingredient experimentation.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by deep cultural familiarity with traditional medicine ingredients supporting mental wellness. Ayurvedic principles in India and Traditional Chinese Medicine practices across the region have long incorporated mood-balancing herbs and botanicals into daily consumption, creating inherent consumer acceptance. Rapid urbanization, rising disposable incomes, and escalating work-related stress expand the addressable consumer base seeking accessible mental wellness solutions. International functional food brands entering these markets through strategic partnerships, combined with local manufacturers developing regionally relevant formulations, accelerate adoption across this vast region.
Key players in the market
Some of the key players in Mood Food Market include Nestle S.A., Unilever PLC, PepsiCo, Inc., The Coca-Cola Company, Danone S.A., Mondelez International, Inc., General Mills, Inc., Kellogg Company, Yakult Honsha Co., Ltd., Yakult Danone India Pvt. Ltd., Hain Celestial Group, Inc., SunOpta Inc., Nature's Path Foods, Oatly Group AB, and Laird Superfood, Inc.
In February 2026, Yakult announced the European launch of Yakult Vitals, a new dairy-free fermented soy drink fortified with Vitamin D and minerals, targeting the vegan functional beverage market.
In February 2026, Nestle announced the formal engagement process to find potential partners for its Waters & Premium Beverages business, with plans for full deconsolidation by 2027 to focus on high-growth areas like Coffee and Medical Nutrition.
In December 2025, Unilever completed the demerger of its Ice Cream business, listing The Magnum Ice Cream Company N.V. as a standalone entity to allow Unilever to focus on high-margin functional and personal care markets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.